Sandoz Ltd

We are a pioneer and a global leader in biosimilars with over a decade of experience. We invest in research and development to improve the lives of patients and liberate healthcare resources through increased access to high-quality, affordable biologics. We have a unique heritage in pharmaceutical biotechnology and advancing biologic care, that dates back to the 1940s with the development of penicillin. In 1980, Sandoz produced one of the first recombinant proteins, an interferon alfa7. Sandoz also has over 25 years of experience in biosimilar development1 – longer than any other company.